| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Osimertinib Mesylate API |
AZD9291(甲磺酸鹽) |
1421373-66-1 |
詳細
|
| Sacubitril/Valsartan intermediates |
LCZ696中間體 |
1426129-50-1 |
詳細
|
| Trelagliptin intermediate 2-Bromomethyl-4-fluoro benzonitrile |
2-氰基-5-氟溴芐 |
421552-12-7 |
詳細
|
| Molnupiravir API |
EIDD-2801 |
2349386-89-4 |
詳細
|
| Baricitinib intermediate 3 |
4-氯吡咯并嘧啶 |
3680-69-1 |
詳細
|
| Lapatinib |
拉帕替尼 |
231277-92-2 |
詳細
|
| Alogliptin Base |
阿格列汀 |
850649-61-5 |
詳細
|
| Cisplatin |
順鉑 |
15663-27-1 |
詳細
|
| Tofacitinib Citrate API |
枸櫞酸托法替尼 |
540737-29-9 |
詳細
|
| Ticagrelor Intermediates4,6-Dichloro-2-propylsulfanyl-pyrimidin-5-ylamine |
4,6-二氯 -2-(丙硫基)-5-氨基嘧啶 |
145783-15-9 |
詳細
|
| Sorafenib |
索拉非尼 |
284461-73-0 |
詳細
|
| Ticagrelor Intermediates 3-Carboxy-2,3-dihydroxy-propionate6-(2-hydroxy-ethoxy)-2,2-dimethyl-tetrahydro-cyclopenta[1,3]dioxol-4- |
2-[[(3AR,4S,6R,6AS)-6-氨基四氫-2,2-二甲基-4H-環(huán)戊并-1,3-二惡茂-4-基]氧基]-乙醇 (2R,3R)-2,3-二羥基丁二酸鹽 |
376608-65-0 |
詳細
|
| Tenofovir Alafenamide N-2 |
泰諾福韋艾拉酚胺 |
379270-37-8 |
詳細
|
| Osimertinib N-3 |
AZD9291中間體2 |
1421372-94-2 |
詳細
|
| Sacubitril intermediates(2R,4S)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-amino-2-methylpentanoate hydrochloride |
（2R，4S）-4-氨基-5-（聯(lián)苯-4-基）-2-甲基戊酸乙酯鹽酸鹽 |
149690-12-0 |
詳細
|
| Tianeptine sodium salt |
噻奈普汀鈉 |
30123-17-2 |
詳細
|
| Alogliptin intermediate 3-Methyl-6-Chlorouracil |
3-甲基-6氯脲嘧啶 |
4318-56-3 |
詳細
|
| Nicotine Intermediates MYOSMINE |
麥司明 |
532-12-7 |
詳細
|
| Atracurium besilate API |
苯磺酸阿曲庫銨 |
64228-81-5 |
詳細
|
| Baloxavir marboxil Intermediates |
(R)-7-芐氧基-3,4,12,12A-四氫-1H-[1,4]聯(lián)氮[3,4-C]吡啶并[2,1-F][1,2,4]三嗪-6,8-二酮 |
1985607-70-2 |
詳細
|
| Molnupiravir N-1 |
((3AR,4R,6R,6AR)-6-(4-(羥氨)-2-惡嘧啶-1(2H)-甲基)-2,2-二甲基四氫呋喃[3,4-D][1,3]二氧醇-4-基)異丁酸甲酯 |
2346620-55-9 |
詳細
|
| Creatine phosphate disodium salt |
磷酸肌酸鈉 |
922-32-7 |
詳細
|
| Nafamostat mesylate |
甲磺酸萘莫司他 |
82956-11-4 |
詳細
|